14 results on '"Kapłon-Cieślicka A"'
Search Results
2. Clinical and echocardiographic characterization of patients hospitalized for severe tricuspid valve regurgitation: a single tertiary-care center experience with 2-year follow-up.
- Author
-
Piasecki, Adam, Tomaniak, Mariusz, Gumiężna, Karolina, Kurzyna, Paweł, Bednarek, Adrian, Skulimowska, Julia, Pędzich, Ewa, Kapłon-Cieślicka, Agnieszka, Rdzanek, Adam, and Scislo, Piotr
- Published
- 2024
- Full Text
- View/download PDF
3. Can transesophageal echocardiography be safely omitted in patients scheduled for elective ablation of atrial arrhythmias? Data based on the LATTEE registry.
- Author
-
Kaufmann, Damian, Królak, Tomasz, Dąbrowska-Kugacka, Alicja, Kapłon-Cieślicka, Agnieszka, Gawałko, Monika, Budnik, Monika, Uziębło-Życzkowska, Beata, Krzesiński, Paweł, Starzyk, Katarzyna, Wożakowska-Kapłon, Beata, Wójcik, Maciej, Błaszczyk, Robert, Hiczkiewicz, Jarosław, Budzianowski, Jan, Mizia-Stec, Katarzyna, Wybraniec, Maciej T., Kosmalska, Katarzyna, Fijałkowski, Marcin, Szymańska, Anna, and Dłużniewski, Mirosław
- Published
- 2024
- Full Text
- View/download PDF
4. Egzamin z kardiologii. Tom 1
- Author
-
Balsam, Paweł, primary, Bielecka-Dąbrowa, Agata, additional, Błach, Anna, additional, Brociek, Emil, additional, Budaj-Fidecka, Anna, additional, Byczkowska, Katarzyna, additional, Chabior, Aleksandra, additional, Cichocka-Radwan, Anna, additional, Czepczor, Kinga, additional, Dobrowolski, Piotr, additional, Domienik-Karłowicz, Justyna, additional, Drożdż, Jarosław, additional, Filipiak-Strzecka, Dominika, additional, Gabryel, Łukasz, additional, Galas, Agata, additional, Gąsior, Zbigniew, additional, Gierlotka, Marek, additional, Góral, Piotr, additional, Holcman, Katarzyna, additional, Imiela, Anna, additional, Imiela, Tomasz, additional, Januszewicz, Andrzej, additional, Januszewicz, Magdalena, additional, Jedrzejczyk-Patej, Ewa, additional, Kapłon-Cieślicka, Agnieszka, additional, Kasperowicz, Krzysztof, additional, Kępski, Jarosław, additional, Kopeć, Grzegorz, additional, Kosiński, Przemysław, additional, Kozłowska, Bogna, additional, Krzesiński, Paweł, additional, Krzowski, Bartosz, additional, Kupczyńska, Karolina, additional, Kurzyna, Marcin, additional, Kuśmierczyk, Mariusz, additional, Lelonek, Małgorzata, additional, Lenarczyk, Radosław, additional, Leszek, Przemysław, additional, Lipiec, Piotr, additional, Mazurek, Michał, additional, Mielczarek, Szymon, additional, Mizia-Stec, Katarzyna, additional, Morawiec, Robert, additional, Nowak, Marcin M., additional, Ochijewicz, Dorota, additional, Opolski, Grzegorz, additional, Ozierański, Krzysztof, additional, Pasierski, Michał, additional, Pawlak, Agnieszka, additional, Piątkowski, Radosław, additional, Podolski, Maciej, additional, Prejbisz, Aleksander, additional, Pyziak-Stepień, Marta, additional, Rajska, Ewa, additional, Rubiś, Paweł, additional, Rymuza, Bartosz, additional, Sacha, Jerzy, additional, Skrobucha, Alicja, additional, Słomka, Sebastian, additional, Sobieszczańska-Małek, Małgorzata, additional, Sokolska, Justyna M., additional, Stępniewski, Jakub, additional, Suwalski, Piotr, additional, Szczerba, Ewa, additional, Szmit, Sebastian, additional, Szymański, Piotr, additional, Tomaszek, Aleksandra, additional, Torbicki, Adam, additional, Tymińska, Agata, additional, Wieteska-Mirek, Maria, additional, Witowicz, Anna, additional, Wojakowski, Wojciech, additional, Wrona, Katarzyna, additional, Załęska-Kocięcka, Marta, additional, Zawadka, Mateusz, additional, and Żurawska, Małgorzata, additional
- Published
- 2024
- Full Text
- View/download PDF
5. Egzamin z kardiologii. Tom 3
- Author
-
Balsam, Paweł, primary, Blamek, Sławomir, additional, Błach, Anna, additional, Braksator, Wojciech, additional, Budaj-Fidecka, Anna, additional, Budnik, Monika, additional, Burban, Anna, additional, Ciepłucha, Aleksandra, additional, Ciurzyński, Michał, additional, Czupryniak, Leszek, additional, Darocha, Szymon, additional, Dąbrowski, Rafał, additional, Dorniak, Karolina, additional, Dyrbuś, Maciej, additional, Dziewięcka, Ewa, additional, Elwertowski, Michał, additional, Ferens, Antoni, additional, Fojt, Anna, additional, Gackowski, Andrzej, additional, Gajewska, Magdalena, additional, Gajos, Grzegorz, additional, Gałązka, Zbigniew, additional, Gawałko, Monika, additional, Gąsecka, Aleksandra, additional, Główczynska, Renata, additional, Grabowski, Marcin, additional, Grodecki, Kajetan, additional, Haberka, Maciej, additional, Huczek, Zenon, additional, Januszkiewicz, Łukasz, additional, Jędrzejczyk-Patej, Ewa, additional, Jonik, Szymon, additional, Kapłon-Cieślicka, Agnieszka, additional, Kaszczewski, Piotr, additional, Kazimierczyk, Ewelina, additional, Kazimierczyk, Remigiusz, additional, Kępka, Cezary, additional, Kobylecka, Małgorzata, additional, Kochman, Janusz, additional, Kołodzińska, Agnieszka, additional, Kołtowski, Łukasz, additional, Konwerski, Michał, additional, Kosek-Nikołajczuk, Małgorzata, additional, Kowalik, Robert, additional, Kowara, Michał, additional, Kozyra-Pydyś, Eliza, additional, Koźluk, Edward, additional, Król, Wojciech, additional, Krzowski, Bartosz, additional, Kupczyńska, Karolina, additional, Kurnicka, Katarzyna, additional, Kuśmierczyk, Mariusz, additional, Kwieciński, Jacek, additional, Lenarczyk, Radosław, additional, Lichodziejewska, Barbara, additional, Lodziński, Piotr, additional, Maciejewski, Cezary, additional, Małecki, Robert, additional, Małyszko, Jolanta, additional, Mamcarz, Artur, additional, Marchel, Michał, additional, Mazurek, Maciej, additional, Mazurek, Michał, additional, Męcka, Klaudia, additional, Miśkowiec, Dawid, additional, Mizia-Stec, Katarzyna, additional, Ochotny, Romuald, additional, Opolski, Maksymilian P., additional, Oręziak, Artur, additional, Orszulak, Michał, additional, Ostrowska, Ewa, additional, Ozierański, Krzysztof, additional, Pachciński, Olaf, additional, Pasierski, Michał, additional, Peller, Michał, additional, Petryka-Mazurkiewicz, Joanna, additional, Piątkowska, Agnieszka, additional, Piotrowicz, Ewa, additional, Piotrowicz, Ryszard, additional, Pruszczyk, Piotr, additional, Rajewska-Tabor, Justyna, additional, Rogozik, Joanna, additional, Rogula, Sylwester, additional, Rokicki, Jakub, additional, Ryś-Czaporowska, Anna, additional, Stępień-Adamczewska, Violetta, additional, Stępińska, Janina, additional, Strzelczyk, Jakub, additional, Styczyński, Grzegorz, additional, Suwalski, Piotr, additional, Szczałuba, Krzysztof, additional, Szczerba, Ewa, additional, Śpiewak, Mateusz, additional, Świerżyńska, Ewa, additional, Tajstra, Mateusz, additional, Tomaniak, Mariusz, additional, Tycińska, Agnieszka, additional, Tymińska, Agata, additional, Wełnicki, Marcin, additional, Winciunas, Piotr Artur, additional, and Zaleska, Martyna, additional
- Published
- 2024
- Full Text
- View/download PDF
6. Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF).
- Author
-
Maciorowska, Małgorzata, Uziębło-Życzkowska, Beata, Gorczyca-Głowacka, Iwona, Wożakowska-Kapłon, Beata, Jelonek, Olga, Wójcik, Maciej, Błaszczyk, Robert, Kapłon-Cieślicka, Agnieszka, Gawałko, Monika, Tokarek, Tomasz, Rajtar-Salwa, Renata, Bil, Jacek, Wojewódzki, Michał, Szpotowicz, Anna, Krzciuk, Małgorzata, Bednarski, Janusz, Bakuła-Ostalska, Elwira, Tomaszuk-Kazberuk, Anna, Szyszkowska, Anna, and Wełnicki, Marcin
- Published
- 2024
- Full Text
- View/download PDF
7. Position paper of the Polish Expert Group on the use of pitavastatin in the treatment of lipid disorders in Poland endorsed by the Polish Lipid Association.
- Author
-
Banach, Maciej, Surma, Stanisław, Kapłon-Cieślicka, Agnieszka, Mitkowski, Przemysław, Dzida, Grzegorz, Tomasik, Tomasz, and Mastalerz-Migas, Agnieszka
- Subjects
PITAVASTATIN ,DYSLIPIDEMIA ,LDL cholesterol ,LIPIDS ,ANTILIPEMIC agents - Abstract
Lipid disorders, primarily hypercholesterolemia, are the most common cardiovascular (CV) risk factor in Poland (this applies even 3/4 of people). The low-density lipoprotein cholesterol (LDL-C) serum level is the basic lipid parameter that should be measured to determine CV risk and determines the aim and target of lipid-lowering treatment (LLT). Lipid-lowering treatment improves cardiovascular prognosis and prolongs life in both primary and secondary cardiovascular prevention. Despite the availability of effective lipid-lowering drugs and solid data on their beneficial effects, the level of LDL-C control is highly insufficient. This is related, among other things, to physician inertia and patients' fear of side effects. The development of lipidology has made drugs available with a good safety profile and enabling personalisation of therapy. Pitavastatin, the third most potent lipid-lowering statin, is characterised by a lower risk of muscle complications and new cases of diabetes due to its being metabolised differently. Thus, pitavastatin is a very good therapeutic option in patients at high risk of diabetes or with existing diabetes, and in patients at cardiovascular risk. This expert opinion paper attempts at recommendation on the place and possibility of using pitavastatin in the treatment of lipid disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. European Society of Cardiology: the 2023 Atlas of Cardiovascular Disease Statistics.
- Author
-
Timmis A, Aboyans V, Vardas P, Townsend N, Torbica A, Kavousi M, Boriani G, Huculeci R, Kazakiewicz D, Scherr D, Karagiannidis E, Cvijic M, Kapłon-Cieślicka A, Ignatiuk B, Raatikainen P, De Smedt D, Wood A, Dudek D, Van Belle E, and Weidinger F
- Subjects
- Humans, Europe epidemiology, Female, Male, Aged, Middle Aged, Cardiology statistics & numerical data, Adult, Adolescent, Child, Child, Preschool, Young Adult, Aged, 80 and over, Infant, Infant, Newborn, Healthcare Disparities statistics & numerical data, Risk Factors, Sex Distribution, Global Burden of Disease trends, Cardiovascular Diseases epidemiology, Cardiovascular Diseases mortality, Societies, Medical
- Abstract
This report from the European Society of Cardiology (ESC) Atlas Project updates and expands upon the 2021 report in presenting cardiovascular disease (CVD) statistics for the ESC member countries. This paper examines inequalities in cardiovascular healthcare and outcomes in ESC member countries utilizing mortality and risk factor data from the World Health Organization and the Global Burden of Disease study with additional economic data from the World Bank. Cardiovascular healthcare data were collected by questionnaire circulated to the national cardiac societies of ESC member countries. Statistics pertaining to 2022, or latest available year, are presented. New material in this report includes contemporary estimates of the economic burden of CVD and mortality statistics for a range of CVD phenotypes. CVD accounts for 11% of the EU's total healthcare expenditure. It remains the most common cause of death in ESC member countries with over 3 million deaths per year. Proportionately more deaths from CVD occur in middle-income compared with high-income countries in both females (53% vs. 34%) and males (46% vs. 30%). Between 1990 and 2021, median age-standardized mortality rates (ASMRs) for CVD decreased by median >50% in high-income ESC member countries but in middle-income countries the median decrease was <12%. These inequalities between middle- and high-income ESC member countries likely reflect heterogeneous exposures to a range of environmental, socioeconomic, and clinical risk factors. The 2023 survey suggests that treatment factors may also contribute with middle-income countries reporting lower rates per million of percutaneous coronary intervention (1355 vs. 2330), transcatheter aortic valve implantation (4.0 vs. 153.4) and pacemaker implantation (147.0 vs. 831.9) compared with high-income countries. The ESC Atlas 2023 report shows continuing inequalities in the epidemiology and management of CVD between middle-income and high-income ESC member countries. These inequalities are exemplified by the changes in CVD ASMRs during the last 30 years. In the high-income ESC member countries, ASMRs have been in steep decline during this period but in the middle-income countries declines have been very small. There is now an important need for targeted action to reduce the burden of CVD, particularly in those countries where the burden is greatest., (© European Society of Cardiology 2024.)
- Published
- 2024
- Full Text
- View/download PDF
9. Worsening of mitral regurgitation after successful transcatheter tricuspid valve repair.
- Author
-
Rdzanek A, Piasecki A, Pędzich E, Tomaniak M, Kapłon-Cieślicka A, and Scisło P
- Published
- 2024
- Full Text
- View/download PDF
10. Cardiovascular risk factors and cardiovascular diseases in patients with newly diagnosed most common cancers in Poland. Preliminary data from the CONNECT-POL registry.
- Author
-
Styczkiewicz K, Liżewska-Springer A, Lelonek M, Olszowska M, Krakowiak B, Styczkiewicz M, Iwański MA, Sokołowski A, Kapłon-Cieślicka A, Kochańska A, and Lewicka E
- Published
- 2024
- Full Text
- View/download PDF
11. Incidence and predictors of device-related thrombus after left atrial appendage closure with Watchman device.
- Author
-
Maksym J, Scisło P, Kapłon-Cieślicka A, Huczek Z, Marchel M, Kochman J, Zbroński K, Opolski G, Grabowski M, and Mazurek T
- Abstract
Introduction: Left atrial appendage closure (LAAC) with Watchman device prevents thromboembolism in patients with atrial fibrillation (AF). However, thrombus may develop on the atrial surface of the device., Aim: To investigate the incidence and predictors of device-related thrombus (DRT) in patients with AF who were treated with LAAC., Material and Methods: Ninety-one consecutive patients with AF underwent LAAC procedure using first-generation Watchman 2.5 device followed by antiplatelet therapy. In our analysis we have included all patients ( n = 78) who had clinical follow-up visits with transesophageal echocardiography (TEE) after the procedure., Results: The median (IQR) CHA
2 DS2 -VASc score was 4 (4.0-6.0) and HAS-BLED score was 3 (3.0-4.0). DRTs were observed in 5 (6.4%) patients. When compared with patients without DRT, those with DRT presented more often with lower median ejection fraction (40% (23.5-45.5) versus 55% (48.0-60.0); p = 0.005), lower emptying velocity of LAA (25 cm/s (17.5-27.0) versus 53 cm/s (26.5-78.0); p = 0.009), and with greater depth of implantation (18 mm (14.0-20.5) versus 8 mm (5.0-11.0); p < 0.001). Furthermore, patients with DRT had greater depth of LAA (35 mm (29.5-41.0) versus 29 mm (25.5-31.0); p = 0.003), greater mean (SD) dimension in 900 (22.4 mm (3.2) versus 19 mm (2.7); p = 0.02). Patients with DRT were also younger than those without DRT (67.4 years (7) versus 75 years (8.3), p = 0.045)., Conclusions: The DRT after Watchman device implantation remains a rare complication. Its formation was related to several patient and procedural characteristics, which need to be confirmed in larger studies., Competing Interests: The authors declare no conflict of interest., (Copyright: © 2024 Termedia Sp. z o. o.)- Published
- 2024
- Full Text
- View/download PDF
12. Oral anticoagulation therapy in atrial fibrillation patients at high risk of bleeding: Clinical characteristics and treatment strategies based on data from the Polish multicenter register of atrial fibrillation (POL-AF).
- Author
-
Maciorowska M, Uziębło-Życzkowska B, Gorczyca-Głowacka I, Wożakowska-Kapłon B, Jelonek O, Wójcik M, Błaszczyk R, Kapłon-Cieślicka A, Gawałko M, Tokarek T, Rajtar-Salwa R, Bil J, Wojewódzki M, Szpotowicz A, Krzciuk M, Bednarski J, Bakuła-Ostalska E, Tomaszuk-Kazberuk A, Szyszkowska A, Wełnicki M, Mamcarz A, and Krzesiński P
- Subjects
- Aged, Female, Humans, Male, Administration, Oral, Anticoagulants adverse effects, Creatinine, Gastrointestinal Hemorrhage chemically induced, Gastrointestinal Hemorrhage complications, Gastrointestinal Hemorrhage drug therapy, Poland, Risk Factors, Aged, 80 and over, Atrial Fibrillation complications, Atrial Fibrillation drug therapy, Stroke drug therapy, Stroke etiology, Stroke prevention & control
- Abstract
Background: Despite its benefits, oral anticoagulant (OAC) therapy in patients with atrial fibrillation (AF) is associated with hemorrhagic complications., Aims: We aimed to evaluate clinical characteristics of AF patients at high risk of bleeding and the frequency of OAC use as well as identify factors that predict nonuse of OACs in these patients., Methods: Consecutive AF patients hospitalized for urgent or planned reasons in cardiac centers were prospectively included in the registry in 2019. Patients with HAS-BLED ≥3 (high HAS-BLED group) were assumed to have a high risk of bleeding., Results: Among 3598 patients enrolled in the study, 29.2% were at high risk of bleeding (44.7% female; median [Q1-Q3] age 72 [65-81], CHA2DS2-VASc score 5 [4-6], HAS-BLED 3 [3-4]). In this group, 14.5% of patients did not receive OACs, 68% received NOACs, and 17.5% VKAs. In multivariable analysis, the independent predictors of nonuse of oral OACs were as follows: creatinine level (odds ratio [OR], 1.441; 95% confidence interval [CI], 1.174-1.768; P <0.001), a history of gastrointestinal bleeding (OR, 2.918; 95% CI, 1.395-6.103; P = 0.004), malignant neoplasm (OR, 3.127; 95% CI, 1.332-7.343; P = 0.009), and a history of strokes or transient ischemic attacks (OR, 0.327; 95% CI, 0.166-0.642; P = 0.001)., Conclusions: OACs were used much less frequently in the group with a high HAS-BLED score than in the group with a low score. Independent predictors of nonuse of OACs were creatinine levels, a history of gastrointestinal bleeding, and malignant neoplasms. A history of stroke or transient ischemic attack increased the chances of receiving therapy.
- Published
- 2024
- Full Text
- View/download PDF
13. Can transesophageal echocardiography be safely omitted in patients scheduled for elective ablation of atrial arrhythmias? Data based on the LATTEE registry.
- Author
-
Kaufmann D, Królak T, Dąbrowska-Kugacka A, Kapłon-Cieślicka A, Gawałko M, Budnik M, Uziębło-Życzkowska B, Krzesiński P, Starzyk K, Wożakowska-Kapłon B, Wójcik M, Błaszczyk R, Hiczkiewicz J, Budzianowski J, Mizia-Stec K, Wybraniec MT, Kosmalska K, Fijałkowski M, Szymańska A, Dłużniewski M, Haberka M, Kucio M, Michalski B, Kupczyńska K, Tomaszuk-Kazberuk A, Wilk-Śledziewska K, Wachnicka-Truty R, Koziński M, Burchardt P, and Daniłowicz-Szymanowicz L
- Subjects
- Humans, Female, Male, Middle Aged, Aged, Prospective Studies, Atrial Flutter surgery, Atrial Flutter diagnostic imaging, Heart Atria diagnostic imaging, Catheter Ablation, Echocardiography, Transesophageal, Registries, Atrial Fibrillation surgery, Atrial Fibrillation diagnostic imaging
- Abstract
Background: According to the present guidelines, transesophageal echocardiography (TEE) before scheduled catheter ablation (CA) for atrial arrhythmias (atrial fibrillation [AF] or atrial flutter [AFL]) is not deemed obligatory for optimally anticoagulated patients. However, daily clinical practice significantly differs from the recommendations., Aims: We aimed to identify transthoracic echocardiographic parameters that could be useful in identifying patients without left atrial thrombus (LAT), which makes it possible to avoid unnecessary TEE before scheduled CA., Methods: This is a sub-analysis of a multicenter, prospective, observational study - the LATTEE registry. A total of 1346 patients referred for TEE before scheduled CA of AF/AFL were included., Results: LAT was present in 44 patients (3.3%) and absent in the remaining 1302, who were younger, more likely to have paroxysmal AF, and displayed sinus rhythm during TEE. Additionally, they exhibited a lower incidence of heart failure, diabetes, systemic connective tissue disease, and chronic obstructive pulmonary disease. Furthermore, they had a lower CHA2DS2-VASc score and a higher prevalence of direct oral anticoagulants. Echocardiographic parameters, including left ventricular ejection fraction (LVEF) >65%, left atrial diameter (LAD) <40 mm, left atrial area (LAA) <20 cm2, left atrial volume (LAV) <113 ml, and left atrial volume index (LAVI) <51 ml/m2, demonstrated 100% sensitivity and 100% negative predictive value for the absence of LAT and were met by 417 patients. Additional echocardiographic indices: LVEF/LAD ≥1.4, LVEF/LAVI ≥1.6, and LVEF/LAA ≥2.7 identified 57 additional patients, bringing the total of predicted LAT-free patients to 474 (35%)., Conclusions: Simple echocardiographic parameters could help identify individuals for whom TEE could be safely omitted before elective CA due to atrial arrhythmias.
- Published
- 2024
- Full Text
- View/download PDF
14. Artificial intelligence in detecting left atrial appendage thrombus by transthoracic echocardiography and clinical features: the Left Atrial Thrombus on Transoesophageal Echocardiography (LATTEE) registry.
- Author
-
Pieszko K, Hiczkiewicz J, Łojewska K, Uziębło-Życzkowska B, Krzesiński P, Gawałko M, Budnik M, Starzyk K, Wożakowska-Kapłon B, Daniłowicz-Szymanowicz L, Kaufmann D, Wójcik M, Błaszczyk R, Mizia-Stec K, Wybraniec M, Kosmalska K, Fijałkowski M, Szymańska A, Dłużniewski M, Kucio M, Haberka M, Kupczyńska K, Michalski B, Tomaszuk-Kazberuk A, Wilk-Śledziewska K, Wachnicka-Truty R, Koziński M, Kwieciński J, Wolny R, Kowalik E, Kolasa I, Jurek A, Budzianowski J, Burchardt P, Kapłon-Cieślicka A, and Slomka PJ
- Subjects
- Humans, Echocardiography, Transesophageal methods, Stroke Volume, Artificial Intelligence, Ventricular Function, Left, Echocardiography, Risk Factors, Atrial Appendage diagnostic imaging, Atrial Fibrillation complications, Heart Diseases diagnosis, Thrombosis diagnosis
- Abstract
Aims: Transoesophageal echocardiography (TOE) is often performed before catheter ablation or cardioversion to rule out the presence of left atrial appendage thrombus (LAT) in patients on chronic oral anticoagulation (OAC), despite associated discomfort. A machine learning model [LAT-artificial intelligence (AI)] was developed to predict the presence of LAT based on clinical and transthoracic echocardiography (TTE) features., Methods and Results: Data from a 13-site prospective registry of patients who underwent TOE before cardioversion or catheter ablation were used. LAT-AI was trained to predict LAT using data from 12 sites (n = 2827) and tested externally in patients on chronic OAC from two sites (n = 1284). Areas under the receiver operating characteristic curve (AUC) of LAT-AI were compared with that of left ventricular ejection fraction (LVEF) and CHA2DS2-VASc score. A decision threshold allowing for a 99% negative predictive value was defined in the development cohort. A protocol where TOE in patients on chronic OAC is performed depending on the LAT-AI score was validated in the external cohort. In the external testing cohort, LAT was found in 5.5% of patients. LAT-AI achieved an AUC of 0.85 [95% confidence interval (CI): 0.82-0.89], outperforming LVEF (0.81, 95% CI 0.76-0.86, P < .0001) and CHA2DS2-VASc score (0.69, 95% CI: 0.63-0.7, P < .0001) in the entire external cohort. Based on the proposed protocol, 40% of patients on chronic OAC from the external cohort would safely avoid TOE., Conclusion: LAT-AI allows accurate prediction of LAT. A LAT-AI-based protocol could be used to guide the decision to perform TOE despite chronic OAC., (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.